Just be aware the they have a buyer on the line. The rub and the hold up is the finale price. Only a smart CEO will pull the trigger. 18 to 20 billion is a lot of money for a small company! The reason is their are lot companies with average drugs. Afrezza will assume 80% of the diabetic market. The world market would be worth 200 billion annually. Who will step up? The buyer will be the hero and all the rest will be goats when they lose their business! This sell with zero notice! Alfred should announce the offer. But he won't !